Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya

NCT02137707 · clinicaltrials.gov ↗

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis-Relapsing-Remitting

Interventions

DRUG: Gilenya

Sponsor

McGill University

Collaborators

[object Object]